MedPath

广东星昊药业有限公司

Ownership
-
Established
2005-06-13
Employees
-
Market Cap
-
Website
http://www.sunho.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

58

NMPA:58

Drug Approvals

Bortezomib for Injection

Product Name
注射用硼替佐米
Approval Number
国药准字H20253697
Approval Date
Mar 25, 2025
NMPA

安神补脑分散片

Approval Number
国药准字Z20090754
Approval Date
Apr 15, 2024
NMPA

Sarcandra dispersion tablets

Product Name
肿节风分散片
Approval Number
国药准字Z20090290
Approval Date
Mar 15, 2024
NMPA

Meglumine Adenosine Cyclophosphate Injection

Product Name
环磷腺苷葡胺注射液
Approval Number
国药准字H22024608
Approval Date
Mar 15, 2024
NMPA

Ligustrazine Hydrochloride Injection

Product Name
盐酸川芎嗪注射液
Approval Number
国药准字H22025223
Approval Date
Mar 15, 2024
NMPA

Tranexamic Acid Injection

Product Name
氨甲环酸注射液
Approval Number
国药准字H20198009
Approval Date
Feb 20, 2024
NMPA

Tiopronin for Injection

Product Name
注射用硫普罗宁
Approval Number
国药准字H20198007
Approval Date
Feb 2, 2024
NMPA

Alprostadil for Injection

Product Name
注射用前列地尔
Approval Number
国药准字H22026343
Approval Date
Feb 2, 2024
NMPA

Alprostadil for Injection

Product Name
注射用前列地尔
Approval Number
国药准字H22026344
Approval Date
Feb 2, 2024
NMPA

Docetaxel Injection

Product Name
多西他赛注射液
Approval Number
国药准字H20237179
Approval Date
Dec 20, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.